BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23507573)

  • 1. Minireview: nuclear insulin and insulin-like growth factor-1 receptors: a novel paradigm in signal transduction.
    Sarfstein R; Werner H
    Endocrinology; 2013 May; 154(5):1672-9. PubMed ID: 23507573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Effects of Insulin and IGF1 Receptors on ERK and AKT Subcellular Distribution in Breast Cancer Cells.
    Sarfstein R; Nagaraj K; LeRoith D; Werner H
    Cells; 2019 Nov; 8(12):. PubMed ID: 31771180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Nuclear Insulin and IGF1 Receptors in Metabolism and Cancer.
    Werner H; Sarfstein R; Laron Z
    Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33918477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both IGF1R and INSR Knockdown Exert Antitumorigenic Effects in Prostate Cancer In Vitro and In Vivo.
    Ofer P; Heidegger I; Eder IE; Schöpf B; Neuwirt H; Geley S; Klocker H; Massoner P
    Mol Endocrinol; 2015 Dec; 29(12):1694-707. PubMed ID: 26452103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled dimerization of insulin-like growth factor-1 and insulin receptors reveals shared and distinct activities of holo and hybrid receptors.
    Chen J; Nagle AM; Wang YF; Boone DN; Lee AV
    J Biol Chem; 2018 Mar; 293(10):3700-3709. PubMed ID: 29330302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor I receptor signaling and nuclear translocation of insulin receptor substrates 1 and 2.
    Sun H; Tu X; Prisco M; Wu A; Casiburi I; Baserga R
    Mol Endocrinol; 2003 Mar; 17(3):472-86. PubMed ID: 12554758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-β-induced expression of IGFBP-3 regulates IGF1R signaling in human osteosarcoma cells.
    Schedlich LJ; Yenson VM; Baxter RC
    Mol Cell Endocrinol; 2013 Sep; 377(1-2):56-64. PubMed ID: 23831640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic analysis of type-1 insulin-like growth factor receptor signaling through insulin receptor substrate-1 and -2 in pancreatic beta cells.
    Xuan S; Szabolcs M; Cinti F; Perincheri S; Accili D; Efstratiadis A
    J Biol Chem; 2010 Dec; 285(52):41044-50. PubMed ID: 20947509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose concentration and AMP-dependent kinase activation regulate expression of insulin receptor family members in rat islets and INS-1E beta cells.
    Raile K; Klammt J; Laue S; Garten A; Blüher M; Kralisch S; Klöting N; Kiess W
    Diabetologia; 2005 Sep; 48(9):1798-809. PubMed ID: 16052330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin receptor and IGF1R are not required for oocyte growth, differentiation, and maturation in mice.
    Pitetti JL; Torre D; Conne B; Papaioannou MD; Cederroth CR; Xuan S; Kahn R; Parada LF; Vassalli JD; Efstratiadis A; Nef S
    Sex Dev; 2009; 3(5):264-72. PubMed ID: 19851056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imprinted Grb10, encoding growth factor receptor bound protein 10, regulates fetal growth independently of the insulin-like growth factor type 1 receptor (Igf1r) and insulin receptor (Insr) genes.
    Moorwood K; Smith FM; Garfield AS; Ward A
    BMC Biol; 2024 May; 22(1):127. PubMed ID: 38816743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
    Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of ganitumab (AMG 479), alone and in combination with rapamycin, in Ewing's and osteogenic sarcoma models.
    Beltran PJ; Chung YA; Moody G; Mitchell P; Cajulis E; Vonderfecht S; Kendall R; Radinsky R; Calzone FJ
    J Pharmacol Exp Ther; 2011 Jun; 337(3):644-54. PubMed ID: 21385891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systems Analysis of Insulin and IGF1 Receptors Networks in Breast Cancer Cells Identifies Commonalities and Divergences in Expression Patterns.
    Sarfstein R; Yeheskel A; Sinai-Livne T; Pasmanik-Chor M; Werner H
    Front Endocrinol (Lausanne); 2020; 11():435. PubMed ID: 32733384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy.
    Tognon CE; Sorensen PH
    Expert Opin Ther Targets; 2012 Jan; 16(1):33-48. PubMed ID: 22239439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development.
    Louvi A; Accili D; Efstratiadis A
    Dev Biol; 1997 Sep; 189(1):33-48. PubMed ID: 9281335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic functions of IGF1R and INSR in prostate cancer include enhanced tumor growth, cell migration and angiogenesis.
    Heidegger I; Kern J; Ofer P; Klocker H; Massoner P
    Oncotarget; 2014 May; 5(9):2723-35. PubMed ID: 24809298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged vs transient roles for early cell cycle signaling components.
    Rose DW; Xiao S; Pillay TS; Kolch W; Olefsky JM
    Oncogene; 1998 Aug; 17(7):889-99. PubMed ID: 9780005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin.
    Zhang H; Pelzer AM; Kiang DT; Yee D
    Cancer Res; 2007 Jan; 67(1):391-7. PubMed ID: 17210722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Insulin Receptor in Breast Cancer Using Small Engineered Protein Scaffolds.
    Chan JY; Hackel BJ; Yee D
    Mol Cancer Ther; 2017 Jul; 16(7):1324-1334. PubMed ID: 28468775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.